Roivant Sciences Ltd.

By person

21 insiders · 293 transactions

916×

Matthew Gline holds 916 times base salary in stock. $664.73M of shares against $725.00K in salary for 2025.

Salary from the company's own proxy. The shares are what Matthew Gline last reported holding, valued at $39.90, the price Common Shares was last bought or sold at on the open market here, on 8 Sep 2026.

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

Gold Daniel Allen

Director

—

$341.57M (36)

−$341.57M

22,649,927

3.14%

$903.73M

−82.9%

QVT Financial LP entity

Director by Deputization

—

$300.69M (32)

−$300.69M

13,689,166

1.90%

$546.20M

−88.6%

MANCHESTER KEITH S

Director

—

$258.62M (30)

−$258.62M

15,437,569

2.14%

$615.96M

−81.0%

SVF Investments (UK) Ltd entity

10% owner

—

$242.63M (3)

−$242.63M

73,031,667

10.11%

$2.91B

−26.5%

Ramaswamy Vivek

10% owner

—

$224.96M (17)

−$224.96M

47,011,612

6.51%

$1.88B

−21.5%

Venker Eric

President & Immunovant CEO

—

$200.44M (90) scheduled

−$200.44M

1,599,154

0.2214%

$63.81M

+15.1%

Sumitomo Chemical Co., Ltd. entity

10% owner

—

$130.00M (1)

−$130.00M

71,251,083

9.86%

$2.84B

−17.5%

VIKING GLOBAL INVESTORS LP entity

10% owner

—

$128.70M (4)

−$128.70M

12,884,307

1.78%

$514.08M

−50.2%

VIKING GLOBAL PERFORMANCE LLC entity

10% owner

—

$128.70M (4)

−$128.70M

12,884,307

1.78%

$514.08M

−50.2%

Sukhatme Mayukh

President & CIO

—

$124.75M (17) scheduled

−$124.75M

18,630,739

2.58%

$743.37M

+515.9%

Torti Frank

President and Vant Chair

—

$82.04M (3) scheduled

−$82.04M

13,536,202

1.87%

$540.09M

—

Gline Matthew

CEO

$49.96K (1)

$71.78M (16) scheduled

−$71.73M

16,659,945

2.31%

$664.73M

+890.7%

Dexcel Pharma Technologies Ltd. entity

10% owner

$20.15M (3)

—

+$20.15M

102,849,443

14.24%

$4.10B

+4.1%

Kumar Rakhi

Chief Accounting Officer

—

$9.87M (25) scheduled

−$9.87M

162,306

0.0225%

$6.48M

−38.8%

Pulik Richard

CFO

—

$9.14M (3) scheduled

−$9.14M

271,810

0.0376%

$10.85M

+16.1%

Fitzgerald Meghan

Director

—

$3.07M (3) scheduled

−$3.07M

41,220

0.0057%

$1.64M

—

Epperly Melissa B,

Director

—

$1.81M (3)

−$1.81M

14,838

0.0021%

$592.04K

—

Humes Jennifer

Chief Accounting Officer

—

$384.07K (1)

−$384.07K

109,782

0.0152%

$4.38M

—

Oren Ilan

Director

—

118,626

0.0164%

$4.73M

—

MOMTAZEE JAMES C

Director

—

106,905

0.0148%

$4.27M

—

Lo Andrew

Director

—

52,142

0.0072%

$2.08M

—

By person

Individual transactions

What was left out